135 related articles for article (PubMed ID: 38134204)
1. Is perioperative chemotherapy effective in patients with localized myxoid liposarcoma?
Masunaga T; Tsukamoto S; Nitta Y; Honoki K; Fujii H; Akahane M; Takeda M; Tanaka Y; Mavrogenis AF; Errani C; Kawai A
Jpn J Clin Oncol; 2024 Mar; 54(3):297-304. PubMed ID: 38134204
[TBL] [Abstract][Full Text] [Related]
2. Comparison of pre-operative and post-operative radiotherapy in patients with localized myxoid liposarcoma.
Masunaga T; Tsukamoto S; Honoki K; Fujii H; Kido A; Akahane M; Tanaka Y; Mavrogenis AF; Errani C; Kawai A
Jpn J Clin Oncol; 2023 Dec; 53(12):1153-1161. PubMed ID: 37814462
[TBL] [Abstract][Full Text] [Related]
3. Myxoid/round cell and pleomorphic liposarcomas: prognostic factors and survival in a series of patients treated at a single institution.
Fiore M; Grosso F; Lo Vullo S; Pennacchioli E; Stacchiotti S; Ferrari A; Collini P; Lozza L; Mariani L; Casali PG; Gronchi A
Cancer; 2007 Jun; 109(12):2522-31. PubMed ID: 17510918
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic prognostic factors of pure myxoid liposarcoma of the extremities and trunk wall.
Nishida Y; Tsukushi S; Nakashima H; Ishiguro N
Clin Orthop Relat Res; 2010 Nov; 468(11):3041-6. PubMed ID: 20499293
[TBL] [Abstract][Full Text] [Related]
5. Myxoid liposarcoma: local relapse and metastatic pattern in 43 patients.
Dürr HR; Rauh J; Baur-Melnyk A; Knösel T; Lindner L; Roeder F; Jansson V; Klein A
BMC Cancer; 2018 Mar; 18(1):304. PubMed ID: 29558901
[TBL] [Abstract][Full Text] [Related]
6. Radiosensitivity translates into excellent local control in extremity myxoid liposarcoma: a comparison with other soft tissue sarcomas.
Chung PW; Deheshi BM; Ferguson PC; Wunder JS; Griffin AM; Catton CN; Bell RS; White LM; Kandel RA; O'Sullivan B
Cancer; 2009 Jul; 115(14):3254-61. PubMed ID: 19472403
[TBL] [Abstract][Full Text] [Related]
7. Localized and metastatic myxoid/round cell liposarcoma: clinical and molecular observations.
Hoffman A; Ghadimi MP; Demicco EG; Creighton CJ; Torres K; Colombo C; Peng T; Lusby K; Ingram D; Hornick JL; Wang WL; Ravi V; Lazar AJ; Lev D; Pollock RE
Cancer; 2013 May; 119(10):1868-77. PubMed ID: 23401071
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of prognostic factors and oncological outcomes in patients with limb-localized myxoid liposarcoma.
Büyükceran İ; Erdoğan F; Karadeniz S; Coşkun HS; Dabak N
Jt Dis Relat Surg; 2022; 33(3):616-623. PubMed ID: 36345190
[TBL] [Abstract][Full Text] [Related]
9. Excellent local control rates and distinctive patterns of failure in myxoid liposarcoma treated with conservation surgery and radiotherapy.
Guadagnolo BA; Zagars GK; Ballo MT; Patel SR; Lewis VO; Benjamin RS; Pollock RE
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):760-5. PubMed ID: 17892916
[TBL] [Abstract][Full Text] [Related]
10. Patterns of recurrence in extremity liposarcoma: implications for staging and follow-up.
Pearlstone DB; Pisters PW; Bold RJ; Feig BW; Hunt KK; Yasko AW; Patel S; Pollack A; Benjamin RS; Pollock RE
Cancer; 1999 Jan; 85(1):85-92. PubMed ID: 9921978
[TBL] [Abstract][Full Text] [Related]
11. Myxoid liposarcoma of the ankle: a case report.
Nishio J; Isayama T; Yoshimura I; Ohjimi H; Iwasaki H; Naito M
J Foot Ankle Surg; 2012; 51(1):76-9. PubMed ID: 22018762
[TBL] [Abstract][Full Text] [Related]
12. Surgical Outcomes and Prognostic Factors of Myxoid Liposarcoma in Extremities: A Retrospective Study.
Zheng K; Yu XC; Xu M; Yang Y
Orthop Surg; 2019 Dec; 11(6):1020-1028. PubMed ID: 31721459
[TBL] [Abstract][Full Text] [Related]
13. Retroperitoneal or mesenteric primary liposarcoma: clinical and prognostic evaluations on five cases.
Rosato L; Panier Suffat L; Bertotti L; Perino P; Comello E; Mondini G
G Chir; 2018; 39(1):57-62. PubMed ID: 29549683
[TBL] [Abstract][Full Text] [Related]
14. Breast carcinoma metastasis in recurrent myxoid liposarcoma.
Kabukcuoglu F; Kabukcuoglu Y; Tanik C; Sakiz D; Karsidag S
Pathol Oncol Res; 2009 Sep; 15(3):467-71. PubMed ID: 18987996
[TBL] [Abstract][Full Text] [Related]
15. Myxoid\round cell liposarcoma (MRCLS) revisited: an analysis of 418 primarily managed cases.
Moreau LC; Turcotte R; Ferguson P; Wunder J; Clarkson P; Masri B; Isler M; Dion N; Werier J; Ghert M; Deheshi B;
Ann Surg Oncol; 2012 Apr; 19(4):1081-8. PubMed ID: 22052112
[TBL] [Abstract][Full Text] [Related]
16. Differential sensitivity of liposarcoma subtypes to chemotherapy.
Jones RL; Fisher C; Al-Muderis O; Judson IR
Eur J Cancer; 2005 Dec; 41(18):2853-60. PubMed ID: 16289617
[TBL] [Abstract][Full Text] [Related]
17. Liposarcoma: Clinico-pathological analysis, prognostic factors and survival in a series of 307 patients treated at a single institution.
Muratori F; Frenos F; Bettini L; Matera D; Mondanelli N; Scorianz M; Cuomo P; Scoccianti G; Beltrami G; Greto D; Livi L; Baldi G; Roselli G; Capanna R; Campanacci DA
J Orthop Sci; 2018 Nov; 23(6):1038-1044. PubMed ID: 30007495
[TBL] [Abstract][Full Text] [Related]
18. Solitary pancreatic metastasis of extremity myxoid liposarcoma: a case report and literature review.
Wang D; Wu J; Yu J; Zhang H; Liu H
BMC Cancer; 2018 Nov; 18(1):1121. PubMed ID: 30445938
[TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of peroxisome proliferator-activated receptor-gamma expression in myxoid liposarcoma.
Takeuchi A; Yamamoto N; Shirai T; Hayashi K; Miwa S; Munesue S; Yamamoto Y; Tsuchiya H
BMC Cancer; 2016 Jul; 16():442. PubMed ID: 27401457
[TBL] [Abstract][Full Text] [Related]
20. Myxoid/round cell liposarcoma of the extremities. A clinicopathologic study of 29 cases with particular attention to extent of round cell liposarcoma.
Smith TA; Easley KA; Goldblum JR
Am J Surg Pathol; 1996 Feb; 20(2):171-80. PubMed ID: 8554106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
